|
1
|
Anderson NL and Anderson NG: The human
plasma proteome: history, character and diagnostic prospects. Mol
Cell Proteomics. 1:845–867. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Anderson NL: The clinical plasma proteome:
a survey of clinical assays for proteins in plasma and serum. Clin
Chem. 56:177–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Taylor R and Agius L: The biochemistry of
diabetes. Biochem J. 250:625–640. 1988.PubMed/NCBI
|
|
4
|
Chase HP, Jackson WE, Hoops SL, et al:
Glucose control and the renal and retinal complications of
insulin-dependent diabetes. JAMA. 261:1155–1160. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takahashi S, Uchino H, Shimizu T, et al:
Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c)
in type 2 diabetic patients: usefulness of GA for evaluation of
short-term changes in glycemic control. Endocr J. 54:139–144. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sundsten T and Ortsater H: Proteomics in
diabetes research. Mol Cell Endocrinol. 297:93–103. 2009.
View Article : Google Scholar
|
|
7
|
Brownlee M: Biochemistry and molecular
cell biology of diabetic complications. Nature. 414:813–820. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bousova I, Bakala H, Chudacek R, et al:
Glycation-induced inactivation of aspartate aminotransferase,
effect of uric acid. Mol Cell Biochem. 278:85–92. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hashemi M, Naderi M, Rashidi H, et al:
Impaired activity of serum alpha-1-antitrypsin in diabetes
mellitus. Diabetes Res Clin Pract. 75:246–248. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mohammad TG, Mojtaba R and Mohsen R: Study
of nonenzymatic glycation of transferrin and its effect on
iron-binding antioxidant capacity. Iran J Basic Med Sci.
13:194–199. 2010.
|
|
12
|
Jung T and Grune T: The proteasome and its
role in the degradation of oxidized proteins. IUBMB Life.
11:743–752. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Winter WE and Schatz DA: Autoimmune
markers in diabetes. Clin Chem. 57:168–175. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tessari P, Kiwanuka E, Millioni R, et al:
Albumin and fibrinogen synthesis and insulin effect in type 2
diabetic patients with normoalbuminuria. Diabetes Care. 29:323–328.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peavy DE, Taylor JM and Jefferson LS:
Correlation of albumin production rates and albumin mRNA levels in
livers of normal, diabetic and insulin-treated diabetic rats. Proc
Natl Acad Sci USA. 75:5879–5883. 1978. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Blanton D, Han Z, Bierschenk L, et al:
Reduced serum vitamin D-binding protein levels are associated with
type 1 diabetes. Diabetes. 60:2566–2570. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ceriello A: Fibrinogen and diabetes
mellitus: is it time for intervention trials? Diabetologia.
40:731–734. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Engstrom G, Hedblad B, Eriksson KF, et al:
Complement C3 is a risk factor for the development of diabetes. A
population-based cohort study. Diabetes. 54:570–575. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lapolla A, Brioschi M, Banfi C, et al: On
the search for glycated lipoprotein ApoA-I in the plasma of
diabetic and nephropathic patients. J Mass Spectrom. 43:74–81.
2008. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng FY, Blackburn K, Lin YM, et al:
Absolute protein quantification by LC/MS(E) for global analysis of
salicylic acid-induced plant protein secretion responses. J
Proteome Res. 8:82–93. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Quintao EC, Medina WL and Passarelli M:
Reverse cholesterol transport in diabetes mellitus. Diabetes Metab
Res Rev. 16:237–250. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Vuilleumier N, Bas S, Pagano S, et al:
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in
patients with rheumatoid arthritis. Arthritis Rheum. 62:2640–2650.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Montecucco F, Vuilleumier N, Pagano S, et
al: Anti-Apolipoprotein A-1 auto-antibodies are active mediators of
atherosclerotic plaque vulnerability. Eur Heart J. 32:412–421.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Haas MJ, Horani M, Mreyoud A, et al:
Suppression of apolipoprotein AI gene expression in HepG2 cells by
TNF alpha and IL-1beta. Biochim Biophys Acta. 1623:120–128. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mooradian AD, Haas MJ and Wong NC:
Transcriptional control of apolipoprotein A-I gene expression in
diabetes. Diabetes. 53:513–520. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mallick KA, Joshi MR and Bhat PG: A study
on Apo B100/Apo A-I ratio in uncontrolled type 2 diabetes mellitus.
Int J Appl Biol Pharm Technol. 2:379–384. 2011.
|
|
27
|
Wagner AM and Ordonez-Llanos J:
Apolipoproteins and prediction of fatal myocardial infarction.
Lancet. 359:1863–1864. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zoppini G, Targher G, Chonchol M, et al:
Higher HDL cholesterol levels are associated with a lower incidence
of chronic kidney disease in patients with type 2 diabetes. Nutr
Metab Cardiovasc Dis. 19:580–586. 2009. View Article : Google Scholar : PubMed/NCBI
|
